Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19917885rdf:typepubmed:Citationlld:pubmed
pubmed-article:19917885lifeskim:mentionsumls-concept:C0010068lld:lifeskim
pubmed-article:19917885lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:19917885lifeskim:mentionsumls-concept:C2350390lld:lifeskim
pubmed-article:19917885lifeskim:mentionsumls-concept:C0806140lld:lifeskim
pubmed-article:19917885lifeskim:mentionsumls-concept:C0917874lld:lifeskim
pubmed-article:19917885lifeskim:mentionsumls-concept:C1519941lld:lifeskim
pubmed-article:19917885lifeskim:mentionsumls-concept:C0750502lld:lifeskim
pubmed-article:19917885lifeskim:mentionsumls-concept:C2347957lld:lifeskim
pubmed-article:19917885pubmed:issue22lld:pubmed
pubmed-article:19917885pubmed:dateCreated2009-12-1lld:pubmed
pubmed-article:19917885pubmed:abstractTextMagnetic resonance myocardial perfusion imaging (MRMPI) has a number of advantages over the other noninvasive tests used to detect reversible myocardial ischemia. The majority of previous studies have generally used quantitative coronary angiography as the gold standard to assess the accuracy of MRMPI; however, only an approximate relationship exists between stenosis severity and functional significance. Pressure wire-derived fractional flow reserve (FFR) values <0.75 correlate closely with objective evidence of reversible ischemia. Accordingly, we have compared MRMPI with FFR.lld:pubmed
pubmed-article:19917885pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19917885pubmed:languageenglld:pubmed
pubmed-article:19917885pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19917885pubmed:citationSubsetAIMlld:pubmed
pubmed-article:19917885pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19917885pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19917885pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19917885pubmed:statusMEDLINElld:pubmed
pubmed-article:19917885pubmed:monthDeclld:pubmed
pubmed-article:19917885pubmed:issn1524-4539lld:pubmed
pubmed-article:19917885pubmed:authorpubmed-author:FordIanIlld:pubmed
pubmed-article:19917885pubmed:authorpubmed-author:DargieHenry...lld:pubmed
pubmed-article:19917885pubmed:authorpubmed-author:OldroydKeith...lld:pubmed
pubmed-article:19917885pubmed:authorpubmed-author:LyneJonathanJlld:pubmed
pubmed-article:19917885pubmed:authorpubmed-author:SteedmanTrace...lld:pubmed
pubmed-article:19917885pubmed:authorpubmed-author:WatkinsStuart...lld:pubmed
pubmed-article:19917885pubmed:authorpubmed-author:BezlyakVladim...lld:pubmed
pubmed-article:19917885pubmed:authorpubmed-author:McGeochRossRlld:pubmed
pubmed-article:19917885pubmed:authorpubmed-author:GoodRichardRlld:pubmed
pubmed-article:19917885pubmed:authorpubmed-author:McLaughlinMai...lld:pubmed
pubmed-article:19917885pubmed:authorpubmed-author:CunninghamTon...lld:pubmed
pubmed-article:19917885pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19917885pubmed:day1lld:pubmed
pubmed-article:19917885pubmed:volume120lld:pubmed
pubmed-article:19917885pubmed:ownerNLMlld:pubmed
pubmed-article:19917885pubmed:authorsCompleteYlld:pubmed
pubmed-article:19917885pubmed:pagination2207-13lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:meshHeadingpubmed-meshheading:19917885...lld:pubmed
pubmed-article:19917885pubmed:year2009lld:pubmed
pubmed-article:19917885pubmed:articleTitleValidation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease.lld:pubmed
pubmed-article:19917885pubmed:affiliationGolden Jubilee National Hospital, Department of Cardiology, Beardmore St, Clydebank, Glasgow, G81 4HX. stuwatki@hotmail.comlld:pubmed
pubmed-article:19917885pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19917885pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:19917885pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:19917885pubmed:publicationTypeValidation Studieslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19917885lld:pubmed